Skin Care News

Skin manifestations are common in VEXAS syndrome and evaluating their presentations can assist in genotyping the disease and possibly lead to better diagnoses, according to a study.

The FDA has approved Sofdra gel 12.45% for the treatment of primary axillary hyperhidrosis in adults and children aged 9 years and older, Botanix Pharmaceuticals announced in a press release.

Researchers find that while clinicians agree on diagnostic and treatment practices for pediatric vulvar and perianal lichen sclerosus, management techniques lack uniformity, according to a study.

Dermatologists should be on the lookout for new forms of a highly contagious fungal infection now being reported in the U.S., according to a press release from NYU Langone Health.

Suntegrity Skincare has issued a voluntary recall of nine Impeccable Skin Sunscreen Foundation lots, according to a press release from the FDA.

Hormone replacement therapy may render the skin of postmenopausal women both more prone to inflammation and more capable of repairing itself, according to a study.

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

The FDA has approved the expanded use area of Klisyri to up to 100 cm2 on the face and scalp for the treatment of actinic keratosis, Almirall announced in a press release.

CLEVELAND — In this video perspective from the Cleveland Clinic’s Medical Dermatology Therapy Update III meeting, Adam Brown, MD, a rheumatologist at the institution, discusses what to look for in leukocytoclastic, or cutaneous, vasculitis.

CLEVELAND — While new treatments for cutaneous lupus are on the horizon, sunscreen remains the best way to offset effects, according to J. Michelle Kahlenberg, MD, PhD.